AVIR icon

Atea Pharmaceuticals
AVIR

Overview Fund Activity

107 hedge funds and large institutions have $169M invested in Atea Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
-11
Holders Change %
-9.32%
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
11
Increased
45
Reduced
30
Closed
21
Calls
$292K
Puts
$169K
Net Calls
+$123K
Net Calls Change
-$59K

Top Buyers

1
BlackRock
BlackRock
New York
$28.8M
2
BCM
BML Capital Management
Indiana
$16.7M
3
Morgan Stanley
Morgan Stanley
New York
$2.49M
4
TCM
Tang Capital Management
California
$12.4M
5
Barclays
Barclays
United Kingdom
$601K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$16.3M
2
SCM
Stonepine Capital Management
Oregon
$2.56M
3
SAM
Sectoral Asset Management
Quebec, Canada
$0
4
Vontobel Holding
Vontobel Holding
Switzerland
$0
5
Citadel Advisors
Citadel Advisors
Florida
$528K
Name Holding Trade Value Shares
Change 		Shares
Change %
SC
126
SouthState Corp
Florida
– -$1.7K -565 Closed
CAM
127
Costello Asset Management
Pennsylvania
– -$300 -100 Closed
QC
128
Quent Capital
New York
– -$105 -35 Closed
2 3 4 5
6